Paclitaxel-Coated Versus Uncoated Balloon Angioplasty Reduces Target Lesion Revascularization in Patients With Femoropopliteal Arterial Disease | Zendy

Salvatore Cassese | Zendy; Robert A. Byrne | Zendy; Ilka Ott | Zendy; Gjin Ndrepepa | Zendy; Mateja Nerad | Zendy; Adnan Kastrati | Zendy; Massimiliano Fusaro | Zendy

Open Access

Paclitaxel-Coated Versus Uncoated Balloon Angioplasty Reduces Target Lesion Revascularization in Patients With Femoropopliteal Arterial Disease

Author(s) -

Salvatore Cassese,

Robert A. Byrne,

Ilka Ott,

Gjin Ndrepepa,

Mateja Nerad,

Adnan Kastrati,

Massimiliano Fusaro

Publication year - 2012

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.112.969972

Subject(s) - medicine , angioplasty , restenosis , balloon , revascularization , target lesion , randomized controlled trial , surgery , coronary artery disease , radiology , cardiology , stent , myocardial infarction , percutaneous coronary intervention

In disease of the femoropopliteal artery, paclitaxel-coated balloon (PCB) therapy improved angiographic outcomes as compared with uncoated balloon (UCB) angioplasty. Nevertheless, it remains uncertain whether PCB may reduce the need for reintervention.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research